"head neck squamous cell carcinoma" trang 2 - tải miễn phí từ tailieunhanh
Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies
9    70    2
Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: A pilot study

Fluorescent imaging of superficial head and neck squamous cell carcinoma using a γ-glutamyltranspeptidase-activated targeting agent: A pilot study
8    80    1
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)
9    45    1
Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality

Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality
8    80    1
Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models

Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models
9    41    1
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma
15    45    1
Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients

Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients
11    29    1
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
9    45    1
A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
13    58    1
Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma

Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma
11    34    1
The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex

The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex
24    44    3
Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
19    16    1
Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: A phase I trial
10    21    2
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): A single arm clinical trial protocol

A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): A single arm clinical trial protocol
10    7    1
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma

Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma
9    1    1
Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: A real-world data analysis

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: A real-world data analysis
9    1    1
DATS suppresses invasion of oral squamous cell carcinoma cell lines by reducing matrix metalloproteinase-9 via PI3K/AKT

DATS suppresses invasion of oral squamous cell carcinoma cell lines by reducing matrix metalloproteinase-9 via PI3K/AKT
7    89    0
A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma

A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma
8    65    1
Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma
9    36    1
Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh

Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh
11    72    1